Get the latest Science News and Discoveries

Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Addition of immunotherapy continues to show survival benefit in prolonged follow-up in NRG Oncology trial for primary advanced stage or recurrent endometrial cancer - EurekAlert!

How scientists developed a hantavirus PCR test in a weekend

Epithelial–mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC) - EurekAlert!

« Astronomers Might Use Manganese to Clock the Age of Galaxies

Daily briefing: The next generation of lobsters »